BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25819084)

  • 1. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
    Lotan I; Hellman MA; Steiner I
    Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demyelinating neuropathy in diabetes mellitus.
    Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
    Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP.
    Jann S; Bramerio MA; Beretta S; Koch S; Defanti CA; Toyka KV; Sommer C
    Neurology; 2003 Dec; 61(11):1607-10. PubMed ID: 14663052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
    Bril V; Blanchette CM; Noone JM; Runken MC; Gelinas D; Russell JW
    J Diabetes Complications; 2016; 30(7):1401-7. PubMed ID: 27389526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.
    Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA
    Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical analysis of diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy].
    Sun QL; Sun AP; Fu Y; Fan DS
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):749-752. PubMed ID: 30293336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammatory demyelinating polyneuropathy mimicking diabetic neuropathy in a young female with type 2 diabetes mellitus.
    Wang XL; Dou JT; Zhao-Huilü ; Zhong WW; Lu JM; Pan CY; Mu YM
    Diabetes Res Clin Pract; 2012 May; 96(2):e15-7. PubMed ID: 22293929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy.
    Fleischer M; Lee I; Erdlenbruch F; Hinrichs L; Petropoulos IN; Malik RA; Hartung HP; Kieseier BC; Kleinschnitz C; Stettner M
    J Neuroinflammation; 2021 Apr; 18(1):89. PubMed ID: 33832507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of CIDP in patients with diabetes or CMT1.
    Latov N
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML; Vinik AI
    J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
    De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
    Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
    J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy.
    Tan CY; Arumugam T; Razali SNO; Yahya MA; Goh KJ; Shahrizaila N
    J Clin Neurosci; 2018 Nov; 57():198-201. PubMed ID: 30145079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
    Jann S; Beretta S; Bramerio MA
    Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
    Abraham A; Breiner A; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    Expert Rev Clin Immunol; 2015 Apr; 11(4):537-46. PubMed ID: 25764107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
    Jann S; Bramerio MA; Facchetti D; Sterzi R
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
    Wilson J; Chawla J; Fisher M
    J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prevalence of CIDP and the association of diabetes mellitus.
    Laughlin RS; Dyck PJ; Melton LJ; Leibson C; Ransom J; Dyck PJ
    Neurology; 2009 Jul; 73(1):39-45. PubMed ID: 19564582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of chronic inflammatory demyelinating polyneuropathy.
    Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
    J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.